|
|
|
xtalks.com, webinar
Monday, February 28, 2022 | 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
SpeakersGregory Hale, MD, Senior Medical Director, Hematology & Oncology, MedpaceDr. Gregory Hale is a physician with over 28 years of experience in all phases of clinical development, with expertise in hematopoietic stem cell transplantation, cellular and gene therapies and immuno-oncology. Dr. Hale has served as clinical director of the Transplant and Gene Therapy Program at St. Jude Children’s Research Hospital and medical director of the Division of Hematology/Oncology at Johns Hopkins All Children’s Hospital. Most recently he was Professor of Oncology at Johns Hopkins and has authored more than 200 peer-reviewed manuscripts, review articles and book chapters. He has held leadership positions in the National Marrow Donor Program (NMDP) and the Center for International Blood and Marrow Transplant Registry (CIBMTR). He earned his medical degree from the Joan C. Edwards School of Medicine at Marshall University. He completed his pediatrics residency at Children’s Hospital of Pittsburgh and his pediatric hematology/oncology fellowship at St. Jude Children’s Research Hospital. Message PresenterTanya Konovalenko, MPharm, RAC, Director, Regulatory Affairs, Scientific and Strategic Development, MedpaceTanya Konovalenko has over 25 years of international experience in drug development of small molecules and biologics through all phases of clinical research, authorization and post approval. She has worked in Canada and Switzerland and has served as a principal interface for interactions with major regulatory agencies including EMA, FDA, Health Canada and various National Competent Authorities in Europe. Tanya has extensive experience with pre-submission meetings, interactions and negotiations with the agencies, and has designed and executed effective global regulatory strategies, submission review and post approvals. Message PresenterKyle Haas, MBA, Associate Director, Clinical Trial Manager, MedpaceKyle Haas has over 7 years of experience in clinical research with a strong background in healthcare. As a Clinical Trial Manager, he has collaborated with key opinion leaders and Sponsors worldwide to successfully coordinate and manage operations of Phase 1 to 3 neuromuscular trials. Kyle started at Medpace as a Clinical Research Associate monitoring and managing sites. Kyle obtained his Master of Business Administration and degree in Biology at the University of Cincinnati.
|
|
|
|
|
|
Organized by:
|
|
xtalks.com |
|
Invited Speakers:
|
|
SpeakersGregory Hale, MD, Senior Medical Director, Hematology & Oncology, MedpaceDr. Gregory Hale is a physician with over 28 years of experience in all phases of clinical development, with expertise in hematopoietic stem cell transplantation, cellular and gene therapies and immuno-oncology. Dr. Hale has served as clinical director of the Transplant and Gene Therapy Program at St. Jude Children’s Research Hospital and medical director of the Division of Hematology/Oncology at Johns Hopkins All Children’s Hospital. Most recently he was Professor of Oncology at Johns Hopkins and has authored more than 200 peer-reviewed manuscripts, review articles and book chapters. He has held leadership positions in the National Marrow Donor Program (NMDP) and the Center for International Blood and Marrow Transplant Registry (CIBMTR). He earned his medical degree from the Joan C. Edwards School of Medicine at Marshall University. He completed his pediatrics residency at Children’s Hospital of Pittsburgh and his pediatric hematology/oncology fellowship at St. Jude Children’s Research Hospital.
|
|
|
|
|
|
Deadline for Abstracts:
|
|
na
|
|
|
|
|
|
Registration:
|
|
https://xtalks.com/webinars/the-complexities-of-pediatric-rare-disease-clinical-trials-regulatory-and-operational-strategies-for-success/
|
|
E-mail:
|
|
shunte@xtalks.com
|
|
|
|
|
|
|
|